Article Sidebar
Date Published:
15/12/2023
Abstract Views: 491
Views PDF: 357
Views PDF: 357
Section
Scientific research
How to Cite
Du, T. D., Diep, Y. N., Bùi, T. H. H., Diep, Y. L., Phan, N. P. T., Tran, T. M. L., & Dang, T. N. (2023). DERMATOLOGIC MANIFESTATIONS IN HIV: UNVEILING OPPORTUNISTIC INFECTION. Vietnam Journal of Infectious Diseases, 4(44), 102-112. https://doi.org/10.59873/vjid.v4i44.338
DERMATOLOGIC MANIFESTATIONS IN HIV: UNVEILING OPPORTUNISTIC INFECTION
Main Article Content
Abstract
Clinical practice, HIV-infected patients can be hospitalized for many problems. Especially in patients with late clinical presentation, differential diagnoses are often relatively broad. Besides the clinical symptoms and abnormal laboratory results, skin lesions are common problems in these patients. Cutaneous lesions (if they exist) range from typical to atypical and are crucial and valuable clues for diagnosis. In this article, we review the manifestations and importance of cutaneous lesions that present in HIV-infected patients with opportunistic infections.
Article Details
Keywords
Cskin lesions, HIV, opportunistic infections
References
1. Valle SL, Saxinger C, Ranki A, et al. Diversity of clinical spectrum of HTLV-III infection. Lancet. 1985;1(8424):301-4.
2. Huang XJ, Li HY, Chen DX, et al. Clinical analysis of skin lesions in 796 Chinese HIV- positive patients. Acta Derm Venereol. 2011;91(5):552-6.
3. Munoz-Perez MA, Rodriguez-Pichardo A, Camacho F, Colmenero MA. Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse. Br J Dermatol. 1998;139(1):33-9.
4. Cedeno-Laurent F, Gomez-Flores M, Mendez N, et al. New insights into HIV-1-primary skin disorders. J Int AIDS Soc. 2011;14:5.
5. Le T, Wolbers M, Chi NH, et al. Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Viet
Nam. Clin Infect Dis. 2011;52(7):945-52.
6. Wongkamhla T, Chongtrakool P, Jitmuang A. A case report of Talaromyces marneffei Oro-pharyngolaryngitis: a rare manifestation of Talaromycosis. BMC Infect Dis. 2019;19(1):1034.
7. Khongkunthian P, Isaratanan W, Samaranayake LP, Gelderblom HR, Reichart PA. Case Report. Oro-facial manifestations of Penicillium marneffei infection in a Thai patient with AIDS. Mycoses. 2002;45(9-10):411-4.
8. Motswaledi MH, Visser W. The spectrum of HIV-associated infective and inflammatory dermatoses in pigmented skin. Dermatol Clin. 2014;32(2):211-25.
9. Murphy M, Chedister GR, George V. Non-HPV Perianal and Anorectal Sexually Transmitted Viral Infections. Clin Colon Rectal Surg. 2019;32(5):340-6.
10. Clifford GM, Tully S, Franceschi S. Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer. Clin Infect Dis. 2017;64(9):1228-35.
11. van Rijn VM, Mooij SH, Mollers M, et al. Anal, penile, and oral high-risk HPV infections and HPV seropositivity in HIV-positive and HIVnegative men who have sex with men. PLoS One. 2014;9(3):e92208.
12. Amini AP, Brookes TS, Shah H, et al. The association between penile cancer and HIV infection: A literature review. Int J STD AIDS. 2023;34(4):214-28.
13. Gershon AA, Breuer J, Cohen JI, et al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015;1:15016.
14. Marra F, Parhar K, Huang B, Vadlamudi N. Risk Factors for Herpes Zoster Infection: A MetaAnalysis. Open Forum Infect Dis. 2020;7(1):ofaa005.
15. Wright SW, Johnson RA. Human immunodeficiency virus in women: mucocutaneous manifestations. Clin Dermatol. 1997;15(1):93-111
16.Cohen PR, Grossman ME. Clinical features of human immunodeficiency virus-associated disseminated herpes zoster virus infection--a review of the literature. Clin Exp Dermatol. 1989;14(4):273-6.
17. Werner RN, Nikkels AF, Marinovic B, et al. European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment. J Eur Acad Dermatol Venereol. 2017;31(1):20-9.
18. Rogues AM, Dupon M, Ladner J, et al. Herpes zoster and human immunodeficiency virus infection: a cohort study of 101 coinfected patients. Groupe d'Epidemiologie clinique du SIDA en aquitaine. J Infect Dis. 1993;168(1):245.
19. Veenstra J, Krol A, van Praag RM, et al. Herpes zoster, immunological deterioration and disease progression in HIV-1 infection. AIDS. 1995;9(10):1153-8.
20. Zeng L, Feng S, Yao L, Zhao J, Zhang G. Disseminated Herpes Zoster with Decreased CD4 Counts in a HIV-Infected Patient. Clin Cosmet Investig Dermatol. 2023;16:3165-70.
21. Lidhoo P, Unemori P, Leslie KS, Maurer T. Disseminated herpes zoster with increased CD4 counts in 3 HIV-infected patients. J Am Acad Dermatol. 2009;61(2):345-7.
22. Whitley RJ, Roizman B. Herpes simplex virus infections. Lancet. 2001;357(9267):1513-8.
23. Rigopoulos D, Paparizos V, Katsambas A. Cutaneous markers of HIV infection. Clin Dermatol. 2004;22(6):487-98.
24. Strick LB, Wald A, Celum C. Management of herpes simplex virus type 2 infection in HIV type 1-infected persons. Clin Infect Dis. 2006;43(3):347- 56.
25. Merzel Sabovic EK, Turel G, Sever M. Perianal herpetic ulcer with rapid spreading: a sign of acquired immunodeficiency syndrome (AIDS). Acta Dermatovenerol Alp Pannonica Adriat. 2021;30(4):157-9.
2. Huang XJ, Li HY, Chen DX, et al. Clinical analysis of skin lesions in 796 Chinese HIV- positive patients. Acta Derm Venereol. 2011;91(5):552-6.
3. Munoz-Perez MA, Rodriguez-Pichardo A, Camacho F, Colmenero MA. Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse. Br J Dermatol. 1998;139(1):33-9.
4. Cedeno-Laurent F, Gomez-Flores M, Mendez N, et al. New insights into HIV-1-primary skin disorders. J Int AIDS Soc. 2011;14:5.
5. Le T, Wolbers M, Chi NH, et al. Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Viet
Nam. Clin Infect Dis. 2011;52(7):945-52.
6. Wongkamhla T, Chongtrakool P, Jitmuang A. A case report of Talaromyces marneffei Oro-pharyngolaryngitis: a rare manifestation of Talaromycosis. BMC Infect Dis. 2019;19(1):1034.
7. Khongkunthian P, Isaratanan W, Samaranayake LP, Gelderblom HR, Reichart PA. Case Report. Oro-facial manifestations of Penicillium marneffei infection in a Thai patient with AIDS. Mycoses. 2002;45(9-10):411-4.
8. Motswaledi MH, Visser W. The spectrum of HIV-associated infective and inflammatory dermatoses in pigmented skin. Dermatol Clin. 2014;32(2):211-25.
9. Murphy M, Chedister GR, George V. Non-HPV Perianal and Anorectal Sexually Transmitted Viral Infections. Clin Colon Rectal Surg. 2019;32(5):340-6.
10. Clifford GM, Tully S, Franceschi S. Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer. Clin Infect Dis. 2017;64(9):1228-35.
11. van Rijn VM, Mooij SH, Mollers M, et al. Anal, penile, and oral high-risk HPV infections and HPV seropositivity in HIV-positive and HIVnegative men who have sex with men. PLoS One. 2014;9(3):e92208.
12. Amini AP, Brookes TS, Shah H, et al. The association between penile cancer and HIV infection: A literature review. Int J STD AIDS. 2023;34(4):214-28.
13. Gershon AA, Breuer J, Cohen JI, et al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015;1:15016.
14. Marra F, Parhar K, Huang B, Vadlamudi N. Risk Factors for Herpes Zoster Infection: A MetaAnalysis. Open Forum Infect Dis. 2020;7(1):ofaa005.
15. Wright SW, Johnson RA. Human immunodeficiency virus in women: mucocutaneous manifestations. Clin Dermatol. 1997;15(1):93-111
16.Cohen PR, Grossman ME. Clinical features of human immunodeficiency virus-associated disseminated herpes zoster virus infection--a review of the literature. Clin Exp Dermatol. 1989;14(4):273-6.
17. Werner RN, Nikkels AF, Marinovic B, et al. European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment. J Eur Acad Dermatol Venereol. 2017;31(1):20-9.
18. Rogues AM, Dupon M, Ladner J, et al. Herpes zoster and human immunodeficiency virus infection: a cohort study of 101 coinfected patients. Groupe d'Epidemiologie clinique du SIDA en aquitaine. J Infect Dis. 1993;168(1):245.
19. Veenstra J, Krol A, van Praag RM, et al. Herpes zoster, immunological deterioration and disease progression in HIV-1 infection. AIDS. 1995;9(10):1153-8.
20. Zeng L, Feng S, Yao L, Zhao J, Zhang G. Disseminated Herpes Zoster with Decreased CD4 Counts in a HIV-Infected Patient. Clin Cosmet Investig Dermatol. 2023;16:3165-70.
21. Lidhoo P, Unemori P, Leslie KS, Maurer T. Disseminated herpes zoster with increased CD4 counts in 3 HIV-infected patients. J Am Acad Dermatol. 2009;61(2):345-7.
22. Whitley RJ, Roizman B. Herpes simplex virus infections. Lancet. 2001;357(9267):1513-8.
23. Rigopoulos D, Paparizos V, Katsambas A. Cutaneous markers of HIV infection. Clin Dermatol. 2004;22(6):487-98.
24. Strick LB, Wald A, Celum C. Management of herpes simplex virus type 2 infection in HIV type 1-infected persons. Clin Infect Dis. 2006;43(3):347- 56.
25. Merzel Sabovic EK, Turel G, Sever M. Perianal herpetic ulcer with rapid spreading: a sign of acquired immunodeficiency syndrome (AIDS). Acta Dermatovenerol Alp Pannonica Adriat. 2021;30(4):157-9.